Back to search

France· FR:69302990

LUXTURNA 5 x 1 000 000 000 000 génomes de vecteur/mL, solution à diluer et solvant pour solution injectable

A voretigene neparvovec product containing voretigène néparvovec, registered in France by NOVARTIS EUROPHARM (IRLANDE). The same ATC class is registered in 13 of our 19 countries.

ATC S01XA27

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedLUXTURNA 5 x 1 000 000 000 000 génome…ATCS01XA27REGISTER NO.FR:69302990PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Voretigene neparvovec is registered in 13 of 19 countries.

Countries holding a registration under ATC S01XA27 (voretigene neparvovec), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 8 of them publish a price we can compare per daily dose

Voretigene neparvovec · ATC S01XA27

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
VORETIGÈNE NÉPARVOVEC
Manufacturer
NOVARTIS EUROPHARM (IRLANDE)
Country
France (FR)
ATC code
S01XA27
ATC class
Voretigene neparvovec
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955060796
    1 flacon(s) copolymère de cyclooléfines de 0,5 ml - 2 flacon(s) copolymère de cyclooléfines de 1,7 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/418ce58b-96e5-48aa-a617-6d9c23c1ce04
GET /v1/drugs/418ce58b-96e5-48aa-a617-6d9c23c1ce04?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69302990",
  "date_amm": "2018-11-22",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/18/1331",
  "substance": "VORETIGÈNE NÉPARVOVEC",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution à diluer et  solvant pour solution injectable",
  "voies_administration": "subrétinale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

See everything about voretigene neparvovec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.